Lead-203 as a label for radioimaging

Details Lead-203 as a label for radioimaging Lead-203 as a label for radioimaging

1988-03-30

1990-02-06

Terapane, John F.

Drug, bio-affecting and body treating compositions

Radionuclide or intended radionuclide containing; adjuvant...

A61K 4300

Patent

active

H00007358

ABSTRACT:
A radiopharmaceutical composition comprising a radioactive isotope of lead (Pb-203) in combination with a pharmaceutical or an antibody or antibody fragment and a bifunctional chelating agent. These compositions are especially useful in the imaging and diagnosis of tumors and tumor metastases.

REFERENCES:
patent: 4348376 (1982-09-01), Goldenberg
patent: 4421735 (1983-12-01), Haber et al.
patent: 4732864 (1988-03-01), Tolman

Affiliated with

Also associated with

Rating

Lead-203 as a label for radioimaging does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lead-203 as a label for radioimaging, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lead-203 as a label for radioimaging will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-434121